candesartan cilexetil has been researched along with Brain Vascular Disorders in 3 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S | 1 |
| Ohta, K | 1 |
| Hamaguchi, A | 1 |
| Omura, T | 1 |
| Yukimura, T | 1 |
| Miura, K | 1 |
| Inada, Y | 2 |
| Wada, T | 2 |
| Ishimura, Y | 2 |
| Chatani, F | 1 |
| Ojima, M | 1 |
| Sanada, T | 1 |
| Shibouta, Y | 1 |
| Kanagawa, R | 1 |
| Fujisawa, Y | 1 |
| Nishikawa, K | 2 |
1 review available for candesartan cilexetil and Brain Vascular Disorders
| Article | Year |
|---|---|
Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun | 1998 |
2 other studies available for candesartan cilexetil and Brain Vascular Disorders
| Article | Year |
|---|---|
Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Ben | 1994 |
Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiote | 1997 |